Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Management of Patients Followed for Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

66 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-10

Study Completion Date

2026-04-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients having the following gestures (blood test, change of dressing for cancerous lesion and complete toilet in bed) will be identified by the team of the medical oncology department.

During the first contact (V0), the study will be presented to the patients in order to obtain their consent. Anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.1). The gesture will then be performed and the patient's comfort will be evaluated after the gesture is performed in order to obtain the starting data for the study.

Patients will be reviewed in consultation according to the time recommended for each type of gesture.

During the second contact V1 (between 1 and 9 days after D0) anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.2). Patients will then be randomized. After randomization, the first hypnosis session will be performed at the same time as gesture No. 2 and the patient's comfort will be evaluated after the gesture is performed. The patient will receive the self-hypnosis training on the same day.

A period of 7 ± 2 days will be considered for the learning time of self-hypnosis.

The third contact will take place on day D7+/-2 after V1. During this visit, anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.3). Gesture No.3 will be carried out under the effect of self-hypnosis ± aromatherapy and the measurement of comfort will be carried out immediately afterwards

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Aromatherapy on Wellbeing and Relaxation in Gynae Oncology Patients Post Treatment

NCT06590077

Stress Wellbeing Relaxation

ENROLLING_BY_INVITATION NA

Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)

NCT03250130

Breast Cancer

COMPLETED NA

PSYCHOLOGICAL CARE AND HYPNOSIS IN PATIENTS WITH CANCER

NCT03971773

Hypnosis and Cancer

UNKNOWN NA

Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.

NCT04574609

Breast Cancer

ACTIVE_NOT_RECRUITING NA

Outpatient Oncology Aromatherapy for Symptom Management

NCT04449315

Anxiety Nausea

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Include (V0):

Patients in whom the following procedures must be performed:

* Blood samples via a central catheter with a percutaneous implantable chamber, with a Huber needle
* Peripheral venous samples
* Tumor Lesion Dressing
* Complete toilet in bed will be identified by the team of the medical oncology department. During the first contact (V0), the study will be presented to the patients in order to obtain their consent. After signing the consent and before performing the gesture causing discomfort (gesture No.1), anxiety and well-being will be assessed by the verbal administration of the ESAS scale. The gesture will then be performed and the patient's comfort will be assessed using the ESAS scale after the gesture has been performed in order to obtain the data at the start of the study. An appointment for the V1 visit (between 1 and 9 days after D0) will be set for the next procedure.

First V1 hypnosis session (between 1 and 9 days after D0):

During the second contact at visit V1 (between 1 and 9 days after D0), anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.2). Randomization will take place immediately before performing the procedure. After randomization, the first session of hypnosis +/- aromatherapy will be performed at the same time as gesture No. 2 and the patient's comfort will be evaluated after the gesture is performed. During this hypnosis session, the patient will receive self-hypnosis training according to the group they belong to (self-hypnosis vs self-hypnosis + aromatherapy). An appointment for the realization of the next gesture (gesture No.3) will be set for D7 (+/- 2 days after V1). This period of time (7±2 days) will be considered the learning time for self-hypnosis.

Second V2 hypnosis session (D7+-/ 2 days after V1):

The third contact V2 will take place at (D7+/- 2 days after V1). During this visit, anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.3). Gesture No.3 will be carried out under the effect of self-hypnosis ± aromatherapy and the measurement of comfort will be carried out immediately afterwards.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hypnosis

patients in the hypnosis group will perform self-hypnosis sessions

hypnosis

Intervention Type OTHER

The hypnosis session involves the following steps:

1. Preparation for the activation of the hypnotic trance
2. Activation of the hypnotic trance
3. Deepening the hypnotic trance
4. Maintaining hypnotic trance
5. Coming out of the hypnotic trance

hypnosis with aromatherapy

patients in the hypnosis with aromatherapy group will perform self-hypnosis sessions with inhalation of an essential oil

Hypnosis with aromatherapy

Intervention Type OTHER

for patients in the hypnosis with aromatherapy group, before starting the hypnosis session, they will first choose an essential oil among the 5 proposed.

They will pour a drop on their wrist then they will rub it and inhale deeply.

The hypnosis session involves the following steps:

1. Preparation for the activation of the hypnotic trance
2. Activation of the hypnotic trance
3. Deepening the hypnotic trance
4. Maintaining hypnotic trance
5. Coming out of the hypnotic trance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hypnosis

The hypnosis session involves the following steps:

1. Preparation for the activation of the hypnotic trance
2. Activation of the hypnotic trance
3. Deepening the hypnotic trance
4. Maintaining hypnotic trance
5. Coming out of the hypnotic trance

Intervention Type OTHER

Hypnosis with aromatherapy

for patients in the hypnosis with aromatherapy group, before starting the hypnosis session, they will first choose an essential oil among the 5 proposed.

They will pour a drop on their wrist then they will rub it and inhale deeply.

The hypnosis session involves the following steps:

1. Preparation for the activation of the hypnotic trance
2. Activation of the hypnotic trance
3. Deepening the hypnotic trance
4. Maintaining hypnotic trance
5. Coming out of the hypnotic trance

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged ≥18 years
* Patients followed in medical oncology and by the mobile palliative care support team
* From the first line of chemotherapy
* Patient requiring one of the following procedures:
* Blood samples via a central catheter with a percutaneous implantable chamber, with a Huber needle
* Peripheral venous samples
* Change of dressing for cancerous lesion
* Complete toilet in bed
* Patients who have given their consent
* Patient affiliated with a social security scheme

Exclusion Criteria

* Protected person under guardianship or curatorship,
* Person deprived of liberty
* Person unable to express consent
* Pregnant woman and breastfeeding woman
* History of allergy or intolerance to essential oils
* Patients with cognitive or language disorders that make it impossible to answer the questionnaires
* Psychotic disorders

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No